Summary: South Korean-based Stand Up Therapeutics Co., Ltd. is a gene therapy firm for paralysed individuals with spinal cord damage. Stand Up Therapeutics said that it had inked a contract with VectorBuilder Inc., a global leader in gene delivery technologies, to produce a GMP-grade gene delivery system.

Seoul, South Korea–(Newsfile Corp. – January 11, 2023) – Stand Up Therapeutics Co., Ltd. has emerged as a gene therapy firm where Stand Up Therapeutics and VectorBuilder announced the initiative to supply the initial paraplegic patient’s gene therapy materials. According to Stand Up Therapeutics, VectorBuilder will create and distribute gene therapy products designed by Stand Up Therapeutics in the future under this arrangement. The objective is to control the global market.

Stand Up Therapeutics

About Stand Up Therapeutics Co., Ltd.

Using cutting-edge technologies, Stand Up Therapeutics Co., Ltd. develops gene therapies for nerve cell regeneration by transforming fibroblasts into motor neurons in vivo. Stand Up Therapeutics intends to deploy direct lineage reprogramming technology to treat mild and severely paralysed patients, who make up approximately 1.9% of the world’s population and have suffered spinal cord and brain injuries. Stand Up Therapeutics will expand its pipeline through the development of safer and more effective direct reprogramming techniques and gene therapy.

Advertisement

There is additional material available at http://stutps.com.

Contact email: [email protected]
Contact Number: 02-512-0912
Country: Republic of Korea
Contact Person: Stella Richards

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/151017